Progesterone effects on vaginal cytokines in women with a history of preterm birth
Autor: | Tatyana Peresleni, David Garry, Michael Demishev, David Baker, Christina Kocis, Malini D. Persad |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Physiology Maternal Health Interleukin-1beta Blood Pressure Pathology and Laboratory Medicine Biochemistry Vascular Medicine Labor and Delivery 0302 clinical medicine Pregnancy Interleukin-1alpha Immune Physiology 17 alpha-Hydroxyprogesterone Caproate Medicine and Health Sciences Prospective Studies Lipid Hormones Prospective cohort study Immune Response Progesterone Innate Immune System 030219 obstetrics & reproductive medicine Multidisciplinary Interleukin-13 Obstetrics Gestational age Obstetrics and Gynecology Vagina Hypertension Medicine Gestation Premature Birth Cytokines Female Cohort study medicine.drug Research Article Adult medicine.medical_specialty Adolescent Science Birth weight Immunology Gestational Age Preterm Birth 03 medical and health sciences Signs and Symptoms Diagnostic Medicine Hypertensive Disorders in Pregnancy medicine Humans Vaginitis Inflammation business.industry Infant Newborn Biology and Life Sciences Molecular Development medicine.disease Immunity Innate Hormones Pregnancy Complications Administration Intravaginal 030104 developmental biology Gene Expression Regulation Immune System Birth Interleukin-2 Women's Health Progestins business Hydroxyprogesterone caproate Developmental Biology |
Zdroj: | PLoS ONE PLoS ONE, Vol 13, Iss 12, p e0209346 (2018) |
ISSN: | 1932-6203 |
Popis: | ObjectiveTo determine the effect of intramuscular progesterone on the vaginal immune response of pregnant women with a history of prior preterm birth.MethodsA prospective, cohort study of women at 11-16 weeks gestation, ≥18 years of age, and carrying a singleton pregnancy was conducted from June 2016 to August 2017 after IRB approval. Women in the progesterone arm had a history of preterm birth and received weekly intramuscular 17-hydroxyprogesterone caproate. Controls comprised of women with healthy, uncomplicated pregnancies. Excluded were women with vaginitis, diabetes mellitus, hypertension, or other chronic diseases affecting the immune response. A vaginal wash was performed at enrollment, at 26-28 weeks, and at 35-36 weeks gestation. Samples underwent semi-quantitative detection of human inflammatory markers. Immunofluorescence pixel density data was analyzed and a P value ResultsThere were 39 women included, 10 with a prior preterm birth and 29 controls. The baseline demographics and pregnancy outcomes for both groups were similar in age, parity, race, BMI, gestational age at delivery, mode of delivery, and birth weight. Enrollment cytokines in women with a prior preterm birth, including IL-1 alpha (39.2±25.1% versus 26.1±13.2%; P = 0.04), IL-1 beta (47.9±26.4% versus 24.9±17%; PConclusionThere is an increased cytokine presence in vaginal washings of women at risk for preterm birth which appears to be modified following the administration of 17- hydroxyprogesterone caproate to levels similar to healthy controls. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |